New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
ALS Treatment
ALS Treatment at Stanford
Our doctors are recognized experts in caring for people with amyotrophic lateral sclerosis. We have made significant contributions to the body of research into this difficult disease.
Our program takes a comprehensive approach to treatment that includes:
- Multispecialty team approach that brings together doctors; physical, occupational, speech and respiratory therapists; a genetic counselor; and other professionals in the same clinic to consult about your condition.
- Novel therapies, as well as conventional treatment with medication, such as Rilutek® (riluzole), to slow the progression of the disease.
- Investigative therapies, including clinical trials of medications and devices aimed at managing ALS symptoms.
Specific treatment for ALS will be determined by your doctor based on:
- Your age, overall health, and medical history
- Extent of the disease
- Your tolerance for specific medications, procedures, or therapies
- Expectations for the course of the disease
- Your opinion or preference
Read more about our Neuromuscular Program.
ALS Clinical Trials at Stanford
Our Stanford researchers are participating in research studies to increase their understanding of genes that may cause the disease, mechanisms that can trigger motor neurons to degenerate in ALS, and approaches to stop the progress leading to cell death.
Learn more about treatments for ALS available through our Neuromuscular Program.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.